Log in

NYSE:TDOCTeladoc Health Stock Price, Forecast & News

$228.98
+0.55 (+0.24 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$224.20
Now: $228.98
$230.40
50-Day Range
$157.15
MA: $185.42
$228.43
52-Week Range
$54.58
Now: $228.98
$230.40
Volume1.20 million shs
Average Volume2.77 million shs
Market Capitalization$17.05 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.44
Teladoc Health, Inc. provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers, health plans, health systems, and other entities in approximately 100 countries worldwide. Teladoc Health, Inc. has a collaboration with Cincinnati Children's Hospital Medical Center to develop a consumer pediatric telehealth platform. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.
Read More
Teladoc Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars


Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone203-635-2002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$553.31 million
Book Value$14.01 per share

Profitability

Net Income$-98,860,000.00

Miscellaneous

Employees2,400
Market Cap$17.05 billion
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

Teladoc Health (NYSE:TDOC) Frequently Asked Questions

How has Teladoc Health's stock been impacted by COVID-19 (Coronavirus)?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TDOC stock has increased by 66.7% and is now trading at $228.98. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Teladoc Health?

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Teladoc Health.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Teladoc Health.

How were Teladoc Health's earnings last quarter?

Teladoc Health Inc (NYSE:TDOC) posted its quarterly earnings data on Wednesday, April, 29th. The health services provider reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.35) by $0.05. The health services provider earned $180.80 million during the quarter, compared to analyst estimates of $180.64 million. Teladoc Health had a negative return on equity of 10.60% and a negative net margin of 16.24%. The company's revenue for the quarter was up 40.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.43) earnings per share. View Teladoc Health's earnings history.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health updated its second quarter 2020 After-Hours earnings guidance on Wednesday, April, 29th. The company provided earnings per share (EPS) guidance of -0.28--0.23 for the period, compared to the Thomson Reuters consensus estimate of $-0.3. The company issued revenue guidance of $215-225 million, compared to the consensus revenue estimate of $182.26 million.

What price target have analysts set for TDOC?

25 brokers have issued 1-year price targets for Teladoc Health's stock. Their forecasts range from $80.00 to $250.00. On average, they expect Teladoc Health's stock price to reach $166.13 in the next year. This suggests that the stock has a possible downside of 27.4%. View analysts' price targets for Teladoc Health.

Has Teladoc Health been receiving favorable news coverage?

Media coverage about TDOC stock has trended somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Teladoc Health earned a coverage optimism score of 1.3 on InfoTrie's scale. They also assigned media coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Teladoc Health.

Who are some of Teladoc Health's key competitors?

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Shopify (SHOP), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS), Trade Desk (TTD), Square (SQ), salesforce.com (CRM) and Paypal (PYPL).

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 47)
  • Mr. Peter A. McClennen, Pres & Interim COO (Age 50)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 44)
  • Ms. Stephany Verstraete, Chief Marketing Officer (Age 50)
  • Dr. George Byron Brooks BS EE, M.D., Co-Founder

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (0.84%), Envestnet Asset Management Inc. (0.13%), Spence Asset Management (0.05%), Carnegie Capital Asset Management LLC (0.04%), Legacy Capital Partners Inc. (0.01%) and DNB Asset Management AS (0.01%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist. View institutional ownership trends for Teladoc Health.

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Spence Asset Management, Gradient Investments LLC, Legacy Capital Partners Inc., Carnegie Capital Asset Management LLC, and Arden Trust Co. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete, and William H Frist. View insider buying and selling activity for Teladoc Health.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was acquired by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Envestnet Asset Management Inc., IBM Retirement Fund, and Livforsakringsbolaget Skandia Omsesidigt. View insider buying and selling activity for Teladoc Health.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $228.98.

How big of a company is Teladoc Health?

Teladoc Health has a market capitalization of $17.05 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladoc.com.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.